Enveda Biosciences, a clinical-stage biotech company specializing in AI-powered drug discovery from natural compounds, has announced a $150 million Series D funding round, propelling...
Anagenex and Nimbus Therapeutics (Nimbus) announced they have initiated a research collaboration. Anagenex, a pioneering drug discovery company pairing large-scale data generation with proprietary...